This inventor holds 2 USPTO granted patents and 1 published patent application and 1 EPO patent. Top assignees: Centre Hospitalier Regional Et Universitaire De Lille (Chru), Université De Lille 2 Droit Et Santé. Active years: 2019-2020.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
2 out of 10 
2 out of 13 Years Active: 2019-2020
Title: Bénédicte Oxombre-Vanteghem: Innovator in Neurodegenerative Disease Treatment
Introduction
Bénédicte Oxombre-Vanteghem is a notable inventor based in Arneke, France. He has made significant contributions to the field of pharmaceuticals, particularly in the treatment of neurodegenerative diseases. With a total of 2 patents, his work is recognized for its potential impact on medical science.
Latest Patents
His latest patents focus on novel compounds and their pharmaceutical compositions aimed at treating neurodegenerative diseases. The inventions are directed to compounds of Formula (I), including pharmaceutically acceptable salts or solvates thereof, and their various uses in medical applications.
Career Highlights
Bénédicte has worked with esteemed institutions such as Université de Lille 2 Droit et Santé and Centre Hospitalier Régional et Universitaire de Lille (CHRU). His experience in these organizations has allowed him to collaborate with leading experts in the field.
Collaborations
Some of his notable coworkers include Patricia Melnyk and Patrick Vermersch, who have contributed to his research endeavors.
Conclusion
Bénédicte Oxombre-Vanteghem's innovative work in pharmaceuticals showcases his dedication to advancing treatments for neurodegenerative diseases. His contributions are vital to the ongoing research in this critical area of healthcare.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile